A carregar cotações...
Previsão
| Comprar |
1 |
| Manter |
0 |
| Vender |
0 |
Notícias Ir para o feed de notícias
Dominari Holdings changes terms for Series A warrants and offers reduced exercise price
Dominari Holdings agreed incentive arrangements with holders of Series A warrants and is offering two options: exercise all warrants by September 11, 2026 at a reduced price of $2.20 per share, or exchange unexercised warrants for common shares at a ratio of 1 share for every 5 underlying warrants. If holders choose option A, the company expects gross proceeds of about $2.9 million; under option B approximately 115,000 exchange shares would be issued. After the transactions, about 1.2 million Series A warrants would likely remain outstanding; the potential shares are registered for resale in an effective registration statement, while exchange shares are subject to an exemption. » Mais em de.investing.com
Dominari Holdings: stock rose by around 400% in 2025, strong capital-markets activity
Dominari Holdings recorded a price gain of about 400% in 2025 (from roughly $1.00 to almost $5.00) and is currently trading at approximately $4.19. The company paid dividends of around $22.2 million in 2025, generated revenue of $99.59 million (+691% YoY) and shows a very low P/E ratio of 0.46 and a price‑to‑book of 0.32. Dominari Securities completed numerous transactions, raised nearly $2 billion in capital (including leading roles in issuances) and strengthened liquidity with a current ratio of 4.74, indicating robust financial metrics and further upside potential. » Mais em de.investing.com
Dominari Holdings announces $10 million special dividend
Dominari Holdings will pay a cash special dividend of about $10 million (approximately $0.44 per share), payable around January 23, 2026 to shareholders of record at the close of trading on December 31, 2025. The micro‑cap company, with a market capitalization of roughly $67 million, is unusually issuing a special dividend for the first time despite the stock’s strong rise in 2025. Dominari reports a solid liquidity position (current ratio 4.74) and held about $176.2 million in cash and marketable securities as of September 30, 2025; a previously filed $2 billion shelf registration was withdrawn. Tim Ledwick was also appointed CFO, and the company is pursuing growth opportunities in areas such as AI and data centers. » Mais em de.investing.com
Dividendos históricos Dividendos
Todos os indicadores de dividendos Todos os indicadoresDados financeiros da empresa
| (EUR) | junho de 2026 | YoY |
|---|---|---|
| Receitas | 14,71 mi | 49,15% |
| Ganho bruto | 14,71 mi | 49,15% |
| Ganho líquido | -4,36 mi | 130,96% |
| EBITDA | -2,05 mi | 87,45% |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 37,38 mi |
Número de ações | 24,24 mi |
Máximo/mínimo de 52 semanas | € 5,48 - € 1,53 |
Rentabilidade de dividendos | 65,36% |
Dividendos TTM | € 1,01 |
Beta | 0,88 |
PER (PE Ratio) | -0,49 |
PEG (PEG Ratio) | 0,00 |
P/VC (PB Ratio) | 1,80 |
P/V (PS Ratio) | 0,31 |
Perfil da empresa
A Dominari Holdings Inc., uma empresa de biotecnologia, dedica-se ao desenvolvimento de terapêuticas anticancerígenas de moléculas pequenas. O portefólio de terapêuticas da empresa inclui terapias para o cancro da próstata, o cancro do pâncreas, a leucemia mieloide aguda (LMA) e a leucemia linfoblástica aguda. A empresa está a desenvolver o DHA-dFdC, um candidato a medicamento para o cancro do pâncreas; e o KPC34, um tratamento de moléculas pequenas para a leucemia mieloide aguda e a leucemia linfoblástica aguda. A empresa está também a desenvolver uma plataforma antiviral que inibe a replicação de vírus, incluindo o vírus da gripe, o Ebolavírus e o vírus de Marburg, o SARS-CoV, o MERS-CoV e o SARS-CoV-2. Tem acordos de licença com a University of Texas, a University of Maryland Baltimore, a Silo Pharma Inc. e a Wake Forest University Health Sciences. A empresa era anteriormente conhecida como AIkido Pharma Inc. e mudou o seu nome para Dominari Holdings Inc. em dezembro de 2022. A Dominari Holdings Inc. foi fundada em 1967 e tem sede em Nova Iorque, Nova Iorque.
| Nome | Dominari Holdings |
| CEO | Anthony C. Hayes |
| Sede | New York City,
ny EUA |
| Site | |
| Setor | Finanças |
| Indústria | Serviços financeiros |
| Entrada em bolsa | 18/03/1980 |
| Colaboradores | 36 |
Análise aprofundada
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
NASDAQ | DOMH |
Frankfurt | BP2A.F |
Düsseldorf | BP2A.DU |